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Abstract
The suc1/Cks proteins are well-conserved regulatory components of cyclin-dependent kinases 1 and 2 (CDK1/2). These
small molecular mass proteins form a stable complex with CDK1/2 and are essential for normal regulation of CDKs during
the cell division cycle and for degradation of p27kip1. Despite the high degree of homology between the nine known CDKs,
only CDK1, CDK2 and, to a lesser extent, CDK3 are able to bind to the suc1/Cks proteins. No additional suc1/Cks-related
proteins interacting with other CDKs have been reported. We have purified, from starfish oocytes, a 15 kDa protein,
p15CDKBP, which cross-reacts with anti-Cks antibodies (L. Azzi, L. Meijer, A.C. Ostvold, J. Lew, J.H. Wang, J. Biol.
Chem. 269 (1994)). Following microsequencing of internal peptides and generation of corresponding oligonucleotides we
cloned two cDNAs encoding two closely related proteins, p15A and p15B. The predicted protein sequences display distant
but distinct homology with the Suc1/Cks proteins, including the genuine starfish Cks homologue protein, p9CksMg. P15
transcripts are essentially expressed in oocytes. Recombinant p15B or native p15CDKBP bind a 34 kDa protein cross-
reacting with anti-PSTAIRE antibodies, a feature characteristic of CDK-related proteins. In addition p15B interacts tightly
with CDK4, CDK6, CDK8 and the yeast CDC28-related kinase Pho85, but not with CDK1, CDK2 or CDK7. P15 does
not appear to alter the catalytic activity of the bound kinases. C 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
The division cycle of eukaryotic cells is marked by
distinct transitions between the end of the ¢rst
growth phase (G1) and DNA synthesis (S phase),
and between the end of the second growth phase
(G2) and mitosis (M phase). The past decade has
witnessed a tremendous surge in knowledge of fac-
tors controlling the G1/S and the G2/M transitions of
the cell cycle [2^4]. In particular, transition of the G2/
M boundary is clearly under control of the M phase
promoting factor, a heterodimeric serine/threonine
kinase ubiquitous in all eukaryotes. In yeast, a single
catalytic subunit (termed Cdc28 in Saccharomyces
cerevisiae, and cdc2 in Schizosaccharomyces pombe)
controls both the G2/M and G1/S transitions by in-
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teracting selectively with positive regulatory subunits
known as cyclins [5]. Higher eukaryotes utilise a
more complex scheme involving several di¡erent cat-
alytic subunits interacting with multiple classes of
cyclins to ¢nely tune cell cycle control mechanisms
to additional in£uences such as hormones and
growth factors [6^8].
The ¢rst co-factor interacting with cyclin-depen-
dent kinases (CDKs) was identi¢ed as a high copy
suppressor of temperature sensitive cdc2 mutations
in S. pombe [9]. A protein highly related to the prod-
uct of the S. pombe suc1 gene (p13suc1), cdc28 kinase
subunit 1 (CKS1), was isolated from S. cerevisiae in
a similar manner [10]. Homologues to the yeast suc1/
CKS1 proteins have since been identi¢ed in several
other organisms [11^17]. The high degree of sequence
conservation observed between suc1/Cks proteins
from evolutionary distant organisms is indicative of
a highly conserved and important function for these
proteins. Null mutations of suc1 and CKS1 are lethal
in yeast [18,19], whereas overexpression interferes
with progression of G1 in yeast [17] and oocyte mat-
uration in Xenopus [20]. Controlled repression of
CKS1 in S. cerevisiae does not a¡ect cdc28 kinase
activity [21] while the cdc2 inhibitory e¡ect of suc1
repression in S. pombe apparently depends on the
cyclin partner of cdc2 [22]. Recently, the p9CKShs2
binding e⁄ciency to CDK1 has been shown to be
dependent on both cyclin B association and CDK1
Thr160 activating phosphorylation [23]. Crystal
structures for suc1 and its two human homologues
have been resolved [24^26]. Hexameric assembly of
the human protein in part has suggested a sca¡olding
role of this protein for cell cycle control enzymes
[26]. In contrast, suc1 does not form hexamers [25],
indicating that alternative models must be consid-
ered. However, the suc1/Cks proteins seem to share
the property to dimerise through a L strand inter-
change region, the L hinge motif [27,28]. This dimer-
isation process is involved in the regulation of the
suc1/Cks proteins binding to the CDKs [27^30].
The CDK2 binding a⁄nity for multimeric p9CksHs2
is much weaker compared to the monomeric a⁄nity
[30].
The structural data from CDK2-CksHs1 co-crys-
tals [31] have suggested an adaptor function for these
small CDK co-factors [32]. Indeed the CDK2-
CksHs1 structure shows that p9CksHs1 binding to
CDK2 does not induce conformational change in
the kinase but provides an expanding recognition
surface with a sequence-conserved phosphate binding
region, located on the same side as the CDK cata-
lytic site [31]. This sequence is structurally well con-
served within the suc1/Cks protein family [28].
Studies on the e¡ect of the loss of suc1 function
[22] or of depletion of Xe-p9 from mitotic Xenopus
egg extracts [16] have shown an arrest in mitosis and
accumulation of mitotic cyclins and proposed a pu-
tative role for suc1/cks protein in cyclin degradation.
P13suc1 binds the activated cyclosome [33] and re-
cently Xe-p9, the Xenopus suc1/Cks homologue has
been shown to regulate the phosphorylation of the
anaphase promoting complex (APC) by CDK1/cyclin
B [34]. These results converge towards a substrate
targeting function for the suc1/Cks protein family.
However, in S. cerevisiae, the Cks1 subunit does
not associate with APC but associates directly with
the proteasome [35]. Very recently Cks1 was demon-
strated to be absolutely required for SCFSkp2-medi-
ated ubiquitinylation, targeting and destruction of
p27Kip1 [36^38].
In a previous work, we set out to purify a suc1
homologue from star¢sh oocytes. A 15 kDa protein
was puri¢ed based on cross-reactivity with an anti-
serum directed toward p9CKShs2 [1]. However, this
protein did not interact with CDK1 or CDK2 but
was found to bind to a 35 kDa star¢sh enzyme cross-
reacting with anti-PSTAIRE antibodies [1,39]. Here-
in we describe the molecular cloning of the gene en-
coding this 15 kDa CDK-binding protein and further
characterise some of its properties. In addition, we
describe the molecular cloning of the star¢sh p9CksHs1
homologue cDNA, p9CksMg.
2. Materials and methods
2.1. Protein puri¢cation and sequencing
Puri¢cation of p15 from star¢sh oocytes was ac-
complished as previously described [1]. The puri¢ed
protein was digested with thermolysin and the pep-
tides separated by HPLC. Peptide microsequencing
was performed by Dr. J. D’Alayer, at the Pasteur
Institute, Paris.
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2.2. p15CDKBP cDNA cloning
Total RNA was prepared from star¢sh (Marthas-
terias glacialis) G2 phase oocytes according to the
methods of [40]. Approx. 5 Wg of total RNA were
annealed with 50 pmol of random hexamers and re-
verse transcribed using AMV-reverse transcriptase
(Boehringer Mannheim) as described [41]. Reverse
transcribed total RNA was then utilised as a tem-
plate for polymerase chain reaction (PCR) ampli¢ca-
tion of p15 cDNA sequences. Oligonucleotide prim-
ers based on p15 peptide sequence data and
minimised for degeneracy were employed using stan-
dard PCR reaction conditions. The PCR primers,
dATGATYGGIAARCCHGCIAARCCHTTTGAT-
MG and dYTTIACRTTGTACATICCCCA, were
annealed to template cDNA at 48‡C and primer ex-
tended at 71‡C with Taq DNA polymerase (Prome-
ga) for 30 cycles. A PCR product was obtained, la-
belled by incorporation of [32P]dATP (Amersham)
and employed as a hybridisation probe to screen ap-
prox. 250 000 plaque forming units (pfu) of a star¢sh
cDNA library. The star¢sh library was prepared by
the Pasteur Institute Molecular Oncology Unit
(Lille). Star¢sh cDNA synthesised from poly(A)þ se-
lected RNA was inserted into the EcoRI site of V
NM-1149 and phage were ampli¢ed by infection of
C600-h£ bacteria. The cDNA library was screened
using standard procedures as described [41]. Filters
were washed at a high level of stringency: 65‡C, 30
mM NaCl in sodium citrate bu¡er pH 8.0. The nu-
cleotide sequence was obtained for one of three pos-
itive clones by excising the V EcoRI insert, subclon-
ing into Bluescript SK3 (Stratagene) and sequencing
with a T7 Sequenase kit (Pharmacia) employed ac-
cording to the manufacturer’s instructions. This
clone (p15A) was used to re-screen the same star¢sh
cDNA library for which ¢nal washing of the ¢lters
was at 58‡C, 80 mM NaCl in sodium citrate pH 8.0.
Thirty positive clones were isolated and re-screened
by both single lane (ddATP) sequencing and South-
ern hybridisation at variable stringency. This second-
ary screening identi¢ed an additional p15 cDNA
clone which was also sequenced as described above.
2.3. p9CKS cDNA cloning
Star¢sh G2 phase oocyte total RNA was also re-
verse transcribed with an oligo(dT) primer and the
resulting cDNA then used as a template for PCR
ampli¢cation of cDNA encoding the star¢sh homo-
logue of S. pombe p13suc1. The primers used for PCR
were dGAGGGAGCCG ARTAYMGNCAYGTN-
ATG and dATGGAATTCRAANARNARNATRT-
GNGGYTCNGG. The resulting PCR product was
found to encode a predicted peptide sequence with
similarity to S. pombe p13suc1 and was consequently
used as a hybridisation probe to screen a star¢sh
genomic DNA library. The genomic DNA library
was constructed from Sau3AI partial digests of star-
¢sh (M. glacialis) genomic DNA inserted into the
BamHI site of V dash-II (Stratagene). This library
was also prepared by the Pasteur Institute Molecular
Oncology Unit (Lille).
2.4. RNA analysis
Total RNA was prepared from tissue samples (5 g)
frozen in liquid nitrogen, pulverised and then lysed
with 4 M guanidinium-isothiocyanate as described
[40]. The RNA was quanti¢ed by absorbance at
260 nm, 10 Wg samples were denatured and resolved
by electrophoresis through 1% agarose gels contain-
ing 2.2 M formaldehyde. Following transfer to a
charged nylon membrane (Genescreen-Plus, Du-
pont), the RNAs were hybridised with p15 cDNAs
containing [32P]dATP (Amersham) incorporated by
priming with random hexamers. Hybridisations
were performed at 65‡C in 5USSC (750 mM NaCl,
75 mM sodium citrate pH 7.0) plus 0.2% SDS, 100
Wg/ml denatured salmon sperm DNA (Sigma) for 18
h. Filters were washed to a ¢nal stringency of
0.1USSC, 0.2% SDS at 65‡C for 15 min. Loading




beads were prepared as previously described [1]. Ex-
pression of recombinant p15 was performed by sub-
cloning an RCA-1/BamHI fragment of pBluescript-
p15A into pGEX-4T1 (Pharmacia), and an EcoRI
fragment of pBluescript-p15B into the EcoRI site
of pGEX-2T followed by expression as GST-fusion
proteins according to the manufacturer’s instruc-
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tions. The RcaI restriction enzyme site in p15A was
obtained by introducing a C to T point mutation at
position 94.
Extracts of star¢sh oocytes in G2 or M phase were
prepared as previously described [1]. Recombinant
p15A and p15B bound to glutathione agarose (Sig-
ma), or p9CksHs1-Sepharose, or p15CDKBP-Sepharose
were mixed with oocyte extracts (generally 10 Wl of
packed beads per 500 Wl of extract) for 1 h at 4‡C.
Other extracts (insect cell lysate expressing CDK6/
cyclin D2, Escherichia coli expressed GST-Pho85
and Drosophila embryo nuclear extracts) were also
loaded on control beads (p9CksHs1-Sepharose or
Sepharose CL4B) or on p15CDKBP-Sepharose. Beads
were then collected by centrifugation and washed
three times with wash bu¡er (150 mM NaCl, 50
mM Tris^HCl pH 8.0, 0.05% Tween 20 or 25 mM
HEPES-Kþ, 0.1.mM EDTA, 12.5 mM MgCl2, 100
mM KCl, 1 mM DTT, 1 mM sodium bisulphite,
1 mM benzamidine, 2 mM PMSF, 1% Nonidet
P-40, pH 7.6) for beads loaded with nuclear extracts.
Proteins bound to the beads were then separated by
SDS^PAGE, transferred to nitrocellulose and immu-
noblotted with the appropriate antibodies. Antibod-
ies employed included: anti-PSTAIRE [42] (a gener-
ous gift of Dr. Yamashita), a mouse monoclonal
antibody; anti-p15, a rabbit polyclonal antibody pro-
duced by Neosystems and a⁄nity puri¢ed by adsorp-
tion to p15CDKBP-Sepharose, anti-CDK6, anti-
CDK7, anti-CDK8, anti-cyclin C and anti-CDK1.
3. Results
3.1. cDNA cloning of p15CDKBP
We have previously described the puri¢cation of a
CDK4- and CDK5-binding protein from star¢sh oo-
cytes [1]. This protein was further puri¢ed by prepa-
rative gel electrophoresis, transferred to nitrocellu-
lose and the appropriate band excised and
microsequenced. Four peptide sequences (Fig. 1)
were obtained of which two were chosen for the de-
sign of degenerate oligonucleotide primers (see Sec-
tion 2). These primers were employed for the ampli-
¢cation of a 225 bp fragment from reverse
transcribed star¢sh oocyte RNA. This fragment
was then used to screen a star¢sh oocyte cDNA li-
brary. A poly(A) containing cDNA was obtained
that included a predicted open reading frame for a
protein of 139 amino acids (Fig. 1A). The predicted
protein sequence from this clone (p15A) contained
amino acids which showed some similarity to peptide
sequences obtained by microsequencing of
p15CDKBP from star¢sh oocyte extracts. However,
signi¢cant di¡erences were observed between the
peptide microsequence data and the cDNA predicted
p15CDKBP sequence. One peptide was entirely absent
from the predicted sequence for p15A (compare Fig.
1A,B). Consequently, we conducted a second screen
for additional p15 cDNA. The p15A cDNA was
used to re-screen the star¢sh cDNA library and
from 30 additional positive clones several were found
to contain an additional p15 cDNA sequence (p15B,
Fig. 1B). Nucleotide sequence analysis of this second
p15 cDNA indicated that it also contained an open
reading frame encoding a predicted protein sequence
of 144 amino acids. The predicted amino acid se-
quence of p15B was observed to have a much closer
match to the p15CDKBP microsequence data, con-
taining all four peptide sequences (Fig. 1B). Reanal-
ysis of the microsequencing data (not shown) indi-
cated that the two remaining mismatches within the
predicted sequence of p15CDKBP (Ala and Arg) are
possibly due to ambiguous chromatographic peaks.
3.2. Star¢sh suc1 homologue cloning and sequence
analysis of the p15A and p15B with the p13suc1/
p9Cks family of proteins
Using primers based on the highly conserved suc1
homologues, we succeeded in amplifying a partial
cDNA for a p13 homologue from star¢sh reverse
transcribed RNA. However, despite extensive e¡orts
C
Fig. 1. DNA sequences of star¢sh oocyte clones p15A (A) and p15B (B). The coding sequences are indicated in uppercase and the
predicted amino acid sequence above each codon in lowercase. Uppercase amino acid sequence depicts the peptide sequence data ob-
tained from microsequencing of puri¢ed star¢sh p15CDKBP. Bold uppercase amino acid sequence indicates identity between cDNA
predicted sequence and peptide sequence data.
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with additional primers no additional sequence could
be obtained from reverse transcribed RNA. We were
also unsuccessful in obtaining a star¢sh p9 cDNA
clone by employing the p9 PCR product as a hybrid-
isation probe to screen an oligo(dT) primed star¢sh
cDNA library. However, a star¢sh genomic DNA
library was screened with the p9 PCR product and
an additional clone was detected. This 12 kb genomic
clone from star¢sh contained the p9 sequence ampli-
¢ed by PCR and also extended our sequence infor-
mation towards the 3P end of the star¢sh p9CksMg
coding sequence (Fig. 2). Alignment of p9CksMg
with other suc1 homologues demonstrates that the
star¢sh protein is also highly conserved. Comparing
the conserved domain, the star¢sh p9CksMg protein
shows 66% identity with human p9CksHs1, 62% with
p9CksHs2, 62% with the Xenopus p9CksXl, and 47% and
48% with the yeast proteins p13suc1 and p18CKS1,
respectively (Fig. 2).
Data base searches have not allowed the identi¢-
cation of any proteins with signi¢cant homology to
p15. However, alignment of the predicted star¢sh
p15 sequences with the suc1/Cks proteins demon-
strates that both p15A and p15B have two distinct
regions presenting limited homology with the suc1/
Cks family (45% of identity for YSICLSPDKYE
with suc1 and 54% with CKS1, WRHNYYDERW-
GMY present less than 24% of identity with suc1
Fig. 2. Alignment of star¢sh p15 amino acid sequences with suc1/Cks proteins. S. cerevisiae, CKS1 [10], S. pombe, suc1 [19], Pneumo-
cystis carinii, CksPc (Mubarak et al., AAC15772), Leishmania mexicana, CksLm [15], M. glacialis, CksMg (this work, underlined),
Caenorhabditis elegans, CksCe (Korf and Strome, AAC27123), Patella vulgata, CksPv [12], Drosophila melanogaster, CksDm [14], Xe-
nopus laevis, CksXl [16], Mus musculus, CksMm (Marra et al., P56390), Homo sapiens, CksHs1 and CksHs2 [17], Physarum polycepha-
lum, CksPp [11], and Arabidopsis thaliana, CksAt [13]. The consensus sequence for the suc1/Cks family is shown in uppercase. Lower-
case within the consensus indicates amino acid residues which are ‘preferred’ in the majority of suc1/Cks proteins. The CKS1 protein
secondary structure [28] is indicated below the consensus sequence, K helix (K) and L strand (L). The relationship between p15B and
suc1/Cks proteins is shown with uppercase bold type indicating strict conservation between all proteins, lowercase indicating preferred
residues and asterisk indicating conserved similar amino acids. Where similar amino acids are grouped as hydrophobic non-polar, G,
A, V, L, I, P, F, M, W, C; hydrophilic, N, Q, S, T, Y; acid, D, E; basic, K, R, H.
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and CKS1) (Fig. 2). The highest degree of similarity
is observed between p15 and the yeast suc1 and
CKS1 proteins which, when compared to other
suc1 homologues, have an N-terminal extension of
20 amino acids as well as an internal insertion of
nine amino acids. Additionally, CKS1 has a C-termi-
nal extension of approx. 35 amino acids of which 20
are glutamines. Like suc1 and CKS1, p15A and p15B
are both N-terminally extended, and some similarity
is observed between the p15 sequences and CKS1 in
this segment. Both p15 sequences also contain a
C-terminal extension but with little similarity to
CKS1 as there are only two adjacent glutamines. In
contrast the star¢sh p9CksMg protein compares much
more favourably with the smaller suc1 homologues
of Physarum, Patella, Drosophila, Xenopus, mouse
and human. The important number of cysteine resi-
dues present in both p15 sequences should also be
noticed. These residues are not conserved within the
Suc1/Cks protein sequences.
3.3. p15CDKBP transcripts are restricted to oocytes
The p15B cDNA is 1560 bp and corresponds
closely to the relative molecular size of p15B
mRNA as estimated by migration through agarose
gel (Fig. 3I). The transcripts for both p15A and p15B
were detected exclusively in star¢sh oocytes and we
did not detect mRNA for these proteins in mature or
regenerating tissues (Fig. 3I,IIA, lanes 1 and 2). A
relatively low level of p15B message was detected
in the poly(A)3 fraction of G2 oocytes, indicating
that this message is fully polyadenylated at this stage
(Fig. 3IA, lane 6). However, the same poly(A)3 RNA
fraction was observed to contain substantially more
p15A message (Fig. 3IIA, lane 6), suggesting that a
fraction of the p15A message pool is not polyadeny-
lated in G2 oocytes. Additionally, the p15A cDNA is
1937 bp and does not correspond well to the p15A
message size as observed by Northern blotting (Fig.
3IIA). As estimated by Northern blotting, p15A
mRNA appeared to be smaller than p15B mRNA
(compare Fig. 3IA and IIA, lanes 4). This result
and the observations that a substantial portion of
p15A transcripts remained in the poly(A)3 fraction,
and the lack of p15A message in M phase poly(A)þ
mRNA suggest that p15A transcripts are highly la-
bile and partially degraded even in G2 oocytes.
Interestingly, the star¢sh p9CksMg message was not
detected in P or M phase oocytes (Fig. 3III, lanes 4
and 5), nor was the corresponding protein detected
by Western blotting [1]. This result is, perhaps, not
surprising given the di⁄culty experienced in amplify-
Fig. 3. Northern blot analysis of p15B (I) and p15A (II) and
star¢sh Cks homologue p9CksMg (III) transcripts in star¢sh. (A)
Lanes: 1, immature oocytes; 2, total RNA from regenerating
arm; 3, total RNA from mature arm; 4, total RNA from G2
phase oocytes; 5, total RNA from M phase oocytes; 6, poly-
(A)3 RNA from G2 phase oocytes; 7, poly(A)þ mRNA from
G2 phase oocytes; 8, poly(A)þ mRNA from M phase oocytes.
Approximately equal quantities of RNA were loaded in each
lane as estimated by ethidium bromide staining of a duplicate
gel (B).
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ing and cloning full length star¢sh p9CksMg cDNA
from oocyte mRNA (described in Section 2). Conse-
quently, the partial p9 cDNA originally ampli¢ed
from oocyte RNA was likely derived from a genomic
DNA contamination. Star¢sh p9CksMg message was
detected in immature oocytes (Fig. 3III, lane 1).
These oocytes are morphologically smaller and dark-
er in colour than mature oocytes and they do not
undergo maturation in the presence of 1-methylade-
nine. The presence of star¢sh p9 mRNA uniquely in
immature oocytes suggests a specialised function for
this protein in the initiation and/or progression of
early phases of meiotic division before the G2 arrest.
3.4. Recombinant p15B possesses the same properties
as puri¢ed p15CDKBP and binds a star¢sh
PSTAIRE-immunoreactive protein
Both p15A and p15B were expressed in E. coli as
fusion proteins with glutathione S-transferase. These
recombinant proteins were e⁄ciently expressed,
yielding products that migrated through SDS^
PAGE with their predicted relative molecular mass
(data not shown) and which were detected by anti-
p15 sera (Fig. 4). When mixed with star¢sh oocyte
extracts, p15CDKBP was observed to bind a
PSTAIRE-immunoreactive protein of approx. 34
kDa (Fig. 5, lane 4). Additionally, the GST-p15B
Fig. 5. Both GST-p15B beads and p15CDKBP beads bind a
protein cross-reacting with anti-PSTAIRE antibodies. Anti-
PSTAIRE immunoblot of the bound fraction following incuba-
tion of star¢sh oocyte extracts with p9CksHs1-Sepharose (lane 1),
p15CDKBP-Sepharose (lane 2), GST-p15A (lane 3), GST-p15B
(lane 4) or GST-p15B following CDK1 depletion by four suc-
cessive incubations with p9CksHs1-Sepharose (lane 5).
Fig. 4. Expression of p15A and p15B as GST fusion proteins.
Immunoblot of recombinant GST-p15A (lane 1), native
p15CDKBP from star¢sh G2 phase oocytes (lane 2), GST (lane
3) and recombinant GST-p15B (lane 4) with a⁄nity-puri¢ed
rabbit polyclonal anti-p15CDKBP antibodies. Note that native
p15CDKBP tends to dimerise and to form an apparent 30 kDa
protein (lane 2).
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fusion protein was capable of binding to an anti-
PSTAIRE-immunoreactive protein in star¢sh oocyte
extracts that had been depleted of CDK1/2 by four
successive rounds of binding to p9CksHs1-Sepharose
(Fig. 5, lane 5). Despite approx. 76% identity be-
tween p15A and p15B we did not observe binding
of an anti-PSTAIRE-immunoreactive protein to
GST-p15A.
3.5. p15CDKBP binds several CDKs
As described previously [1,36], p15CDKBP does not
bind CDK1, CDK2 or CDK3. However, p15CDKBP
binds both CDK4 and CDK5 [1]. We looked at oth-
er CDKs for possible binding to p15CDKBP. Nuclear
extracts containing CDK1, CDK7 and CDK8 were
loaded on control-Sepharose and p15CDKBP-Sepha-
rose beads, the bound and unbound proteins were
resolved by SDS^PAGE and immunoblotted with
di¡erent antibodies, anti-CDK8, anti-CDK7, anti-cy-
clin C and anti-CDK1 antibodies (Fig. 6I). CDK8 as
well as cyclin C bind strongly to p15CDKBP-Sepha-
rose, CDK7 binds weakly to p15CDKBP. We also
loaded insect cell lysates containing the expressed
CDK6/cyclin D2 complex on p15CDKBP-Sepharose
beads or p9CksHs1-Sepharose. CDK6 also binds to
p15CDKBP-Sepharose but not to p9CksHs1-Sepharose
(Fig. 6II, top). In S. cerevisiae, Pho85 has been de-
scribed as a CDC28-related protein with a PSTAIRE
motif [43]. E. coli extracts containing GST-Pho85
were loaded on p15CDKBP-Sepharose and p9CksHs1-
Sepharose and the bound material was analysed by
Western blotting with anti-PSTAIRE antibodies
(Fig. 6II, bottom). GST-Pho85 binds well to
p15CDKBP-Sepharose but very weakly to p9CksHs1-
Sepharose.
4. Discussion
4.1. p15CDKBP shows di¡erent isoforms
We have identi¢ed two cDNA encoding similar
proteins, p15A and p15B. In addition a third
cDNA (data not shown) was cloned that possessed
a coding sequence identical to p15A but contained a
di¡erent 3P non-coding sequence. These data are
reminiscent of results obtained by Richardson et al.
[17] who identi¢ed more than one suc1 homologue in
humans. Clearly the two forms of star¢sh p15CDKBP
perform di¡erent functions as only p15B was ob-
served to bind to a PSTAIRE signal. Again, this is
similar to results reported for p9CksHs1 and p9CksHs2,
the human homologues of p13suc1 [17]. These two
proteins are 81% identical yet possess distinct bio-
chemical characteristics and consequently are likely
to have unique molecular functions. We conclude
that the p15B sequence corresponds to the
PSTAIRE-binding p15CDKBP protein puri¢ed from
star¢sh oocytes [1].
4.2. p15CDKBP properties
4.2.1. p15CDKBP binds di¡erent CDKs
p15CDKBP has been described as a CDK4- and
Fig. 6. p15CDKBP binds to di¡erent CDKs. (I) p15CDKBP and
control resins were loaded with nuclear extracts from Drosophi-
la embryos. Extracts: 20 Wl of nuclear extract precleared super-
natant before adsorption (lane 1); CL4B-Sepharose: control
beads after absorption (lane 2); p15CDKBP-Sepharose:
p15CDKBP beads after absorption (lane 3); supernatant: 1/10
supernatant after p15CDKBP-Sepharose adsorption (lane 4). (II)
p15CDKBP and p9CksHs1 adsorption phases were carried out
with insect cell lysate expressing CDK6/cyclin D2 or an E. coli
strain expressing GST-Pho85 extracts. Extracts: crude extract
before adsorption (lane 1); p15CDKBP-Sepharose: p15CDKBP
beads after absorption (lane 2); p9CksHs1-Sepharose: p9CksHs1
beads after absorption (lane 3). The bound and unbound pro-
teins were analysed by immunoblotting using appropriate anti-
bodies.
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CDK5-binding protein [1]. We here show that
p15CDKBP also binds CDK6, CDK8 and Pho85.
CDK1, 2 and 3 are unable to bind to p15CDKBP
[1]. p15CDKBP seems to be able to bind only the
CDKs which do not bind to the suc1/Cks protein
family. p15CDKBP also binds CDKX, a 35 kDa star-
¢sh oocyte protein which cross-reacts with the anti-
PSTAIRE antibodies [1]. This protein shows interest-
ing characteristics which di¡er from the properties of
other CDKs [39].
4.2.2. p15CDKBP is not a kinase inhibitor
We checked for the possible inhibitory e¡ect of
p15CDKBP on the star¢sh prophase oocyte HMG I
kinase activity bound to p15CDKBP and on CDK4/
cyclin D1 [39]. No inhibitory e¡ect was observed,
even with the highest concentration of p15CDKBP
although p16INK4A, used as control, clearly inhibits
the CDK4/cyclin D1 kinase (data not shown).
4.3. Expression of star¢sh p15CDKBP isoforms and
p9CksMg mRNA
The mRNA for CksHs1 and CksHs2 are di¡eren-
tially expressed [17], their three-dimensional struc-
tures are di¡erent [24,26]; CksHs2 forms hexamers
in solution whereas CksHs1 is monomeric [24,26].
The mRNAs for p15A and p15B appear to be ma-
ternal transcripts as we did not observe these
mRNAs in tissues other than oocytes. However,
the partially polyadenylated state of p15A suggests
that p15A and p15B may be subject to di¡erential
translation during oocyte maturation. The absence of
polyadenylated p9CksMg mRNA together with the
lack of immunoreactive p9 in mature G2 arrested
star¢sh oocytes suggests that this protein is not ex-
pressed during the latter stages of star¢sh oocyte
maturation. Alternatively, it is possible that our
anti-p9 sera do not recognise star¢sh p9CksMg, a
rather unlikely possibility, or that the p9CksMg
mRNA is highly labile in mature star¢sh oocytes
and thus degraded or otherwise below the detection
limits of our Northern assays. Nevertheless, the level
of star¢sh p9CksMg message was su⁄ciently elevated
in immature oocytes to be adequately detected. These
results suggest that p9CksMg may have a speci¢c role
during the early stages of star¢sh oogenesis and/or
expression is inhibited or at very low levels in mature
oocytes and other tissues.
4.4. p15CDKBP shows weak yet signi¢cant homology
with the suc1/Cks family proteins
Although the homology between p15A/p15B and
the suc1/Cks family of proteins is weak, we believe
that there is an evolutionary relationship between
these proteins. Two regions that are more highly
conserved between p15B and suc1/Cks proteins are
predicted to form L sheets (data not shown) and are
found between Ser39 and Leu56, and between Trp89
and Arg105 of p15B. Crystallographic data have re-
cently shown that the corresponding regions in
CksHs1 also form L sheets [24,28]. Co-crystals of
CDK2 and CksHs1 indicate that these regions con-
tain residues directly involved in the association of
CksHs1 with CDK2 [31]. Furthermore, the suc1/Cks
protein family shows oligomerisation properties
which seem to play important roles in the function
of suc1/Cks proteins [27,28,31,26,30]. These proper-
ties are in relation with the well conserved motif
HXPEPH which confers to the molecule a L hinge
structure involved in the di¡erent conformations of
the monomeric and oligomeric forms [27,28]. The
corresponding motif in p15B is well conserved in
its chemical properties and we have also observed
on SDS^PAGE loaded with p15CDKBP puri¢ed pro-
tein, a 30 kDa band with the stronger 15 kDa band
(Fig. 4). However, contrary to the suc1/Cks proteins,
the p15 A/B sequences do not present the critical
proline residues shown involved in the monomer/
dimer switch of the domain swapping protein family
[44]. While the overall structure within the two ‘CDK
contact regions’ of p15CDKBP may have been con-
served, there are substantial di¡erences. The critical
residues in CDK contact region 1 of CksHs1 include
Tyr7, Tyr12 and Tyr19, and acidic residues (Asp and
Glu) at positions 13^15. Although p15B does not
have identity with CksHs1 at these particular resi-
dues, a similar linear arrangement of tyrosine and
charged residues has been conserved within the ho-
mologous region of p15B. It should be noted, how-
ever, that the two regions of CDK2 contact with
CksHs1, CDK2 amino acids 205^219 and 232^247,
are not among the most highly conserved motifs ob-
served within the CDK family. Consequently, if par-
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allel regions of CDK4, 5, 6 and 8 are utilised for
binding to p15CDKBP then alternative motifs must
be employed by p15CDKBP. Nevertheless, global
structural features are often conserved within pro-
teins that share a functional commonality. In S.
pombe, p13suc1 also has a similar single domain fold
composed of four central L sheets with exposed ar-
omatic residues [25,28]. It is interesting that the ac-
cessibility of aromatic residues is believed to be im-
portant for protein^protein interactions in general
[25,28,45], and important for the function of suc1/
Cks family proteins in particular [25,28]. Finally, it
is tyrosine residues within p15 sequences that show
the best positional conservation in comparison to
suc1/Cks family proteins.
Because p15A recombinant protein does not bind
to CDKX contrary to p15B, some important resi-
dues involved in these binding properties have to
be found in the residues of p15B di¡erent from those
of p15A. This di¡erence of binding could be due to
one di¡erent residue only without alteration of the
protein structure as shown for mutation of the
p9CksHs2 Glu63 into Gln which eliminates binding
of CDK1 and CDK2 [30].
In conclusion, we have identi¢ed in this study the
cDNA clones for two star¢sh oocyte proteins
(p15CDKBP) which were previously shown to have
unique CDK-binding properties [1,39]. Our results
extend the CDK-binding properties of p15CDKBP.
Indeed, in addition to the ability to bind both
mammalian CDK4 and CDK5, and a star¢sh oocyte
protein named CDKX [1,36], p15CDKBP was also
observed to associate with other CDKs such
as CDK6, CDK8 and the yeast Pho85 protein.
The amino acid sequence of p15A/p15B shows
weak but signi¢cant homologies with the suc1/Cks
protein family. Recent studies have shown the
importance of Xenopus Cks proteins in targeting
the activated CDK2/cyclin A complex towards the
APC [34] and in targeting p27Kip1 to SCFSkp2-medi-
ated ubiquitinylation and destruction [36,38,37].
p13suc1 stimulates the phosphorylation of the cyclo-
some required for full activation of this complex [46].
Furthermore, in Xenopus oocytes the suc1/Cks
homologue, p9CksXl, has also been shown to stimu-
late the phosphorylation (by the CDK1/cyclin
B complex) of proteins such as Wee1, Myt1 and
cdc25, important for the G2/M phase transition
[47]. It will be interesting to investigate these possible
functions for p15CDKBP.
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